Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ORGO · against 110 other Healthcare companies of similar size
Ranked #59 of 111 · scores higher than 46% of peers
Bars: peers in each 10-point band of the profitability score16 peers with a profitability score of 20–29, including ORGO · Click a bar to see the companies
Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | ORGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 80 reported | -27.7% | -13.4% | 42% | 33% | |
| Operating marginHigher is better · 101 reported | -7.8% | -6.3% | 47% | 33% | |
| Return on assetsHigher is better · 117 reported | -20.7% | -6.9% | 33% | 33% | |
| Return on equityHigher is better · 107 reported | -25.9% | -12.8% | 40% | Context only | |
| Gross marginHigher is better · 119 reported | 71.5% | 42.2% | 77% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 592M ILS (≈$160M) | 96 | 84 | |
| 3 | 157M USD | 95 | ||
| 4 | 144.4B KRW (≈$104M) | 88 | 56 | |
| 5 | 244.2B KRW (≈$176M) | 83 | 72 | |
| 54 | 172M USD | 27 | 34 | |
| 57 | 200M USD | 26 | 30 | |
| 58 | 191M USD | 25 | 38 | |
| 59 | 84M CAD (≈$61M) | 23 | 24 | |
| 59 | 107M USD | 23 | 26 | |
| 61 | 110M USD | 22 | 38 | |
| 61 | 124M USD | 22 | 31 | |
| 63 | 1.6B HKD (≈$209M) | 21 | 54 | |
| 64 | 429M HKD (≈$55M) | 20 | 20 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score